HomeMCRB • NASDAQ
add
Seres Therapeutics Inc
Previous close
$14.63
Day range
$14.49 - $15.25
Year range
$6.54 - $29.98
Market cap
135.70M USD
Avg Volume
245.50K
P/E ratio
25.46
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 351.00K | — |
Operating expense | 21.02M | -19.83% |
Net income | 8.20M | -90.76% |
Net profit margin | 2.34K | — |
Earnings per share | 0.94 | 114.24% |
EBITDA | -21.43M | 22.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 47.64M | -28.71% |
Total assets | 143.47M | -19.73% |
Total liabilities | 99.78M | -35.55% |
Total equity | 43.70M | — |
Shares outstanding | 9.05M | — |
Price to book | 2.93 | — |
Return on assets | -39.12% | — |
Return on capital | -45.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 8.20M | -90.76% |
Cash from operations | 2.21M | 106.36% |
Cash from investing | -8.00K | -100.01% |
Cash from financing | 61.00K | 100.06% |
Net change in cash | 2.26M | 151.25% |
Free cash flow | -20.07M | -211.36% |
About
CEO
Founded
2010
Website
Employees
103
